Item 1(a) Name of issuer:Cyclerion Therapeutics Inc.
Item 1(b) Address of issuer’s principal executive offices:301 Binney Street, Cambridge MA 02142
2(a) Name of person filing:
American Endowment Foundation
2(b) Address or principal business office or, if none, residence:
6500 Darrow Road, Suite 118, Hudson, OH 44236
2(c) Citizenship:
See Item 4 of Cover Page
2(d) Title of class of securities:
Common Stock
2(e) CUSIP No.:
See Cover Page
Item 3. | If this statement is filed pursuant to §§240.13d–1(b) or 240.13d–2(b) or (c), check whether the person filing is a: |
| | |
(a) ☐ | | Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o); |
| |
(b) ☐ | | Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c); |
| |
(c) ☐ | | Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c); |
| |
(d) ☐ | | Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a–8); |
| |
(e) ☐ | | An investment adviser in accordance with §240.13d–1(b)(1)(ii)(E); |
| |
(f) ☐ | | An employee benefit plan or endowment fund in accordance with §240.13d–1(b)(1)(ii)(F); |
| |
(g) ☐ | | A parent holding company or control person in accordance with §240.13d–1(b)(1)(ii)(G); |
| |
(h) ☐ | | A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); |
| |
(i) ☐ | | A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a–3); |
| |
(j) ☐ | | Anon-U.S. institution in accordance with §240.13d–1(b)(1)(ii)(J); |
| |
(k) ☐ | | Group, in accordance with §240.13d–1(b)(1)(ii)(K). If filing as anon-U.S. institution in accordance with §240.13d–1(b)(1)(ii)(J), please specify the type of institution: |
Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
(a) Amount beneficially owned:2,660,546
(b) Percent of class: 8.7%